Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

被引：0
|
作者：
Christian Daniel Fankhauser
Sophia Sander
Lisa Roth
Oliver Gross
Daniel Eberli
Tullio Sulser
Burkhardt Seifert
Joerg Beyer
Thomas Hermanns
机构：
[1] University Hospital,Department of Urology
[2] University of Zurich,Department of Oncology
[3] Epidemiology,undefined
[4] Biostatistics and Prevention Institute,undefined
[5] University of Zurich,undefined
[6] University Hospital,undefined
[7] University of Zurich,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
testicular germ cell tumour; systemic inflammatory response; biological markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 830
页数：5
相关论文
共 50 条
  • [21] First-line high-dose chemotherapy for 'poor risk' metastatic non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derigs, HG
    de Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, W
    Gerhartz, H
    Kirchner, H
    Pflüger, K
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    ONKOLOGIE, 1998, 21 : 23 - 25
  • [22] High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
    Pierga, J. -Y.
    Hajage, D.
    Bachelot, T.
    Delaloge, S.
    Brain, E.
    Campone, M.
    Dieras, V.
    Rolland, E.
    Mignot, L.
    Mathiot, C.
    Bidard, F. -C.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 618 - 624
  • [23] Clinical significance of tumor markers as prognostic factors in patients with metastatic gastric cancer receiving first-line chemotherapy.
    Jo, J.
    Ryu, M.
    Koo, D.
    Ryoo, B.
    Kim, H. J.
    Lee, J.
    Chang, H.
    Kim, T. W.
    Choi, K. D.
    Lee, H.
    Jung, H.
    Kim, K. C.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Kim, J.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
    Mario Giuliano
    Antonio Giordano
    Summer Jackson
    Kenneth R Hess
    Ugo De Giorgi
    Michal Mego
    Beverly C Handy
    Naoto T Ueno
    Ricardo H Alvarez
    Michelino De Laurentiis
    Sabino De Placido
    Vicente Valero
    Gabriel N Hortobagyi
    James M Reuben
    Massimo Cristofanilli
    Breast Cancer Research, 13
  • [25] Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
    Giuliano, Mario
    Giordano, Antonio
    Jackson, Summer
    Hess, Kenneth R.
    De Giorgi, Ugo
    Mego, Michal
    Handy, Beverly C.
    Ueno, Naoto T.
    Alvarez, Ricardo H.
    De Laurentiis, Michelino
    De Placido, Sabino
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Reuben, James M.
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH, 2011, 13 (03)
  • [26] Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel
    Novisedlakova, Maria
    Chovanec, Michal
    Ciernikova, Sona
    Danihel Jr, Ludovit
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (11): : 745 - 758
  • [27] Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab
    Jose Ortiz-Morales, M.
    Toledano-Fonseca, Marta
    Mena-Osuna, Rafael
    Teresa Cano, M.
    Gomez-Espana, Auxiliadora
    De la Haba-Rodriguez, Juan R.
    Rodriguez-Ariza, Antonio
    Aranda, Enrique
    CANCERS, 2022, 14 (13)
  • [28] Prognostic role white blood cell levels in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy
    Ioannou, A.
    Demiri, S.
    Papaxoinis, G.
    Rapti, V.
    Klouva, E.
    Sarris, E.
    Baxevanos, P.
    Garefalakis, G.
    Goumas, G.
    Gouveris, P.
    Kourakos, P.
    Koumakis, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Systemic Inflammatory Markers Predicting the Overall Survival of Patients Using Tyrosine Kinase Inhibitors in the First-line Treatment of Metastatic Renal Cell Carcinoma
    Korkmaz, Mustafa
    Erylmaz, Melek Karakurt
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (06): : 653 - 658
  • [30] A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
    Pico, JL
    Rosti, G
    Kramar, A
    Wandt, H
    Koza, V
    Salvioni, R
    Theodore, C
    Lelli, G
    Siegert, W
    Horwich, A
    Marangolo, M
    Linkesch, W
    Pizzocaro, G
    Schmoll, HJ
    Bouzy, J
    Droz, JP
    Biron, P
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1152 - 1159
12345